Lurtotecan is a semisynthetic analogue of camptothecin with antineoplastic activity. Lurtotecan selectively stabilizes the topoisomerase I-DNA covalent complex and forms an enzyme-drug-DNA ternary complex. As a consequence of the formation of this complex, both the initial cleavage reaction and religation steps are inhibited and subsequent collision of the replication fork with the cleaved strand of DNA results in inhibition of DNA replication, double strand DNA breakage and triggering of apoptosis. Independent from DNA replication inhibition, lurtotecan also inhibits RNA synthesis, multi-ubiquitination and degradation of topoisomerase I and chromatin reorganization. The directory classifies it as a discontinued API with a semi-synthetic source/manufacturing origin. Other names for this substance include lurtotecanum and GI147211. Its PubChem CID is 60956.
Lurtotecan
| CAS No | 149882-10-0 |
|---|---|
| Molecular Formula | C28H30N4O6 |
| Molecular Weight | 518.60 g/mol |
| Synonyms | (18S)-18-ethyl-18-hydroxy-2-[(4-methylpiperazin-1-yl)methyl]-6,9,20-trioxa-13,24-diazahexacyclo[12.11.0.03,12.05,10.015,24.017,22]pentacosa-1,3,5(10),11,13,15,17(22)-heptaene-19,23-dione |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Lurtotecan is a semisynthetic analogue of camptothecin with antineoplastic activity. Lurtotecan selectively stabilizes the topoisomerase I-DNA covalent complex and forms an enzyme-drug-DNA ternary complex.
The listed CAS number is 149882-10-0.
The listed molecular formula is C28H30N4O6.
The listed molecular weight is 518.60 g/mol.
(18S)-18-ethyl-18-hydroxy-2-[(4-methylpiperazin-1-yl)methyl]-6,9,20-trioxa-13,24-diazahexacyclo[12.11.0.03,12.05,10.015,24.017,22]pentacosa-1,3,5(10),11,13,15,17(22)-heptaene-19,23-dione.
The source lists lurtotecanum and GI147211.